Tectonic Therapeutic, Inc. (TECX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
TECX currently has 18.8M outstanding shares. with significant dilution risk as 25M authorized shares could dilute existing holders by 133.2%. The company has significantly diluted shareholders by 44.87% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 18.8M shares outstanding |
19M | 25M |
| Nov 06, 2025 |
10-Q filing | 18.7M shares outstanding |
19M | 25M |
| Aug 07, 2025 |
10-Q filing | 18.7M shares outstanding |
19M | 25M |
| Jul 07, 2025 |
POS AM filing: This prospectus relates to the proposed offer and resale of up to 3,689,465 shares of common stock by the selling stockholders of Tectonic Therapeutic, Inc. |
19M | 25M |
| Jul 07, 2025 |
S-3 filing: The company may offer and sell up to $400,000,000 of any combination of common stock, preferred stock, debt securities and warrants. |
17M | 27M |
| Jul 07, 2025 |
POS AM filing: This prospectus relates to the proposed offer and resale or other disposition from time to time by the selling stockholders identified in this prospectus of up to an aggregate of 2,969,583 shares of common stock, par value $0.0001 per share, of Tectonic Therapeutic, Inc. |
19M | 25M |
| May 08, 2025 |
10-Q filing | 17.2M shares outstanding |
17M | 30M |
| Mar 27, 2025 |
POS AM filing: This POS AM filing relates to the proposed offer and resale of up to 2,969,583 shares of common stock by selling stockholders. |
19M | 29M |
| Mar 26, 2025 |
S-1 filing: This S-1 filing relates to the proposed offer and resale of up to 3,689,465 shares of common stock by selling stockholders. |
19M | 32M |
| Mar 20, 2025 |
10-K filing | 18.7M shares outstanding |
19M | 28M |
| Nov 12, 2024 |
10-Q filing | 14.7M shares outstanding |
15M | 32M |
| Aug 14, 2024 |
10-Q filing | 14.7M shares outstanding |
15M | 32M |
| Jul 19, 2024 |
S-1 filing: This S-1 filing is for the resale of up to 2,969,583 shares of common stock by selling stockholders of Tectonic Therapeutic, Inc. |
15M | 32M |
| May 09, 2024 |
10-Q filing | 44.8M shares outstanding |
45M | 0 |
| Mar 14, 2024 |
10-K filing | 44.6M shares outstanding |
45M | 0 |
| Nov 09, 2023 |
10-Q filing | 44.5M shares outstanding |
45M | 0 |
| Aug 10, 2023 |
10-Q filing | 43.7M shares outstanding |
44M | 78K |
| May 11, 2023 |
10-Q filing | 44.1M shares outstanding |
44M | 0 |
| Mar 23, 2023 |
10-K filing | 44.1M shares outstanding |
44M | 0 |
| Nov 08, 2022 |
10-Q filing | 43.8M shares outstanding |
44M | 0 |
| Nov 08, 2022 |
S-3 filing: The company is filing an S-3 to register up to $250,000,000 of common stock, preferred stock, debt securities, warrants and/or units. A supplemental filing includes an offering of common stock having an aggregate offering price of up to $50,000,000. |
44M | 0 |
| Aug 09, 2022 |
10-Q filing | 43.8M shares outstanding |
44M | 0 |
| May 10, 2022 |
10-Q filing | 43.7M shares outstanding |
44M | 0 |
| Mar 17, 2022 |
10-K filing | 43.7M shares outstanding |
44M | 0 |
| Nov 04, 2021 |
10-Q filing | 43.7M shares outstanding |
44M | 0 |
| Aug 05, 2021 |
10-Q filing | 43.6M shares outstanding |
44M | 0 |
| May 13, 2021 |
10-Q filing | 41.8M shares outstanding |
42M | 0 |
| Mar 18, 2021 |
10-K filing | 41.6M shares outstanding |
42M | 0 |
| Nov 05, 2020 |
10-Q filing | 36.5M shares outstanding |
36M | 0 |
| Aug 06, 2020 |
10-Q filing | 36.4M shares outstanding |
36M | 0 |
| May 07, 2020 |
10-Q filing | 36.0M shares outstanding |
36M | 0 |
| Mar 16, 2020 |
10-K filing | 36.0M shares outstanding |
36M | 0 |